Serum levels of MMP11 were previously shown to be significantly higher in patients with lymph node metastasis and was also identified as an independent prognostic factor for 5-year mortality in CRC [63]. This evidence concerns the gene MMP11 and metastatic malignant neoplasm in the lymph nodes.